Abstract
Melatonin is an endogenous neurohormone that is produced in most living organisms, including unicellular and multicellular organisms, plants, vertebrates, and nonvertebrate animals. In diurnal animals, endogenous melatonin functions as a neurohormone and contributes to circadian rhythms. In nocturnal animals, endogenous melatonin no longer functions as a contributor to circadian rhythms. Circadian rhythms control the timing, quantity, and quality of hormones and neurotransmitters that the body produces and eventually secretes. An imbalance of these events creates disturbances in circadian rhythm. During disturbances of circadian rhythm, the body produces hormones, chemicals, and neurotransmitters in aberrant amounts or at the wrong time of day. The human circadian system is synchronized with physiological functions and metabolism. Many studies have reported that exogenous melatonin has analgesic and neuroprotective effects in chronic pain. Considering that chronotherapy may be beneficial for the treatment of chronic pain, the present review describes the properties, possible mechanisms, and function of melatonin in chronic pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acuña Castroviejo D, Escames G, Carazo A, León J, Khaldy H, Reiter RJ (2002) Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr Top Med Chem 2:133–151
Afkhamizadeh M, Sahebari M, Seyyed-hoseini S-R (2014) Morning melatonin serum values do not correlate with disease activity in rheumatoid arthritis: a cross-sectional study. Rheumatol Int 34:1145–1151
Ahn AH, Goadsby PJ (2013) Migraine and sleep: new connections. Cerebrum: the Dana forum on brain science. Dana Foundation
Alóe F, Azevedo APD, Hasan R (2005) Sleep-wake cycle mechanisms. Rev Bras Psiquiatr 27:33–39
Alstadhaug K, Bekkelund S, Salvesen R (2007a) Circannual periodicity of migraine? Eur J Neurol 14:983–988
Alstadhaug K, Salvesen R, Bekkelund S (2007b) Insomnia and circadian variation of attacks in episodic migraine. Headache 47:1184–1188
Altun A, Ugur-Altun B (2007) Melatonin: therapeutic and clinical utilization. Int J Clin Pract 61:835–845
Ambriz-Tututi M, Granados-Soto V (2007) Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors. Pain 132:273–280
Areti A, Yerra VG, Naidu V, Kumar A (2014) Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol 2:289–295
Arreola-Espino R, Urquiza-Marín H, Ambriz-Tututi M, Araiza-Saldaña CI, Caram-Salas NL, Rocha-González HI, Mixcoatl-Zecuatl T, Granados-Soto V (2007) Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats. Eur J Pharmacol 577:203–210
Balzer I, Höcker B, Kapp H, Bartolomaeus B (2000) Occurrence and comparative physiology of melatonin in evolutionary diverse organisms. In: Driessche TV, Guisset JL, Petiau-de Vries GM (eds) The redox state and circadian rhythms. Springer, Dordrecht
Barrett T, Kent S, Voudouris N (2000) Does melatonin modulate beta-endorphin, corticosterone, and pain threshold? Life Sci 66:467–476
Bolten W, Gross M, Brabant T, Weck V, Labenz J (2013) Individual pain treatment with NSAIDs. MMW Fortschr Med 155(59–60):62
Bondi CD, Mckeon RM, Bennett JM, Ignatius PF, Brydon L, Jockers R, Melan MA, Witt-Enderby PA (2008) MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation. J Pineal Res 44:288–298
Bonmati-Carrion MA, Arguelles-Prieto R, Martinez-Madrid MJ, Reiter R, Hardeland R, Rol MA, Madrid JA (2014) Protecting the melatonin rhythm through circadian healthy light exposure. Int J Mol Sci 15:23448–23500
Budhiraja S, Singh J (2005) Adjuvant effect of melatonin on anesthesia induced by thiopental sodium, ketamine, and ether in rats. Methods Find Exp Clin Pharmacol 27:697–700
Buscemi N, Vandermeer B, Hooton N, Pandya r, Tjosvold l, Hartling l, Vohra s, Klassen t P, Baker G (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 332:385–393
Callebert J, Jaunay J, Jallon J (1991) Control of Drosophila biorhythms. Adv Pineal Res 5:81–84
Callsen-Cencic P, Hoheisel U, Kaske A, Mense S, Tenschert S (1999) The controversy about spinal neuronal nitric oxide synthase: under which conditions is it up-or downregulated? Cell Tissue Res 295:183–194
Caumo W, Levandovski R, Hidalgo MPL (2009) Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study. J Pain 10:100–108
Caumo W, Torres F, Moreira NLJR, Auzani JA, Monteiro CA, Londero G, Ribeiro DF, Hidalgo MPL (2007) The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg 105:1263–1271
Cavaletti G, Carozzi V, Chiorazzi A, Oggioni N, Rodriguez-Menendez V, Avezza F, Marmiroli P (2013) Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models. Ital J Anat Embryol 118:51
Chang F-Y (2014) Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol 20:2499
Chen C-Q, Fichna J, Bashashati M, LI Y-Y, Storr M (2011) Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol 17:3888
Chiang RPY, Huang CT, Tsai YJ (2013) Melatonin reduces median nerve injury-induced mechanical hypersensitivity via inhibition of microglial p38 mitogen-activated protein kinase activation in rat cuneate nucleus. J Pineal Res 54:232–244
Costigan M, Woolf CJ (2000) Pain: molecular mechanisms. J Pain 1:35–44
Cutolo M, Maestroni G (2005) The melatonin-cytokine connection in rheumatoid arthritis. Ann Rheum Dis 64:1109–1111
Cutolo M, Maestroni G, Otsa K, Aakre O, Villaggio B, Capellino S, Montagna P, Fazzuoli L, Veldi T, Peets T (2005) Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216
Danilov A, Kurganova J (2016) Melatonin in chronic pain syndromes. Pain and therapy 5:1–17
De Zanette SA, Vercelino R, Laste G, Rozisky JR, Schwertner A, Machado CB, Xavier F, De Souza ICC, Deitos A, Torres IL (2014) Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol 15:40
Demisch L, Demisch K, Nickelsen T (1988) Influence of dexamethasone on nocturnal melatonin production in healthy adult subjects. J Pineal Res 5:317–322
Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G (2007) Hypothalamic activation in spontaneous migraine attacks. Headache 47:1418–1426
Desler C, Lillenes MS, Tønjum T, Rasmussen LJ (2017) The role of mitochondrial dysfunction in the progression of Alzheimer’s disease. Curr Med Chem 24:1–10
Doghramji K (2007) Melatonin and its receptors: a new class of sleep-promoting agents. J Clin sleep Med 3:S17
El-Shenawy SM, Abdel-Salam OM, Baiuomy AR, El-Batran S, Arbid MS (2002) Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol Res 46:235–243
Engstrøm M, Hagen K, Bjørk MH, Stovner LJ, Gravdahl GB, Stjern M, Sand T (2013) Sleep quality, arousal and pain thresholds in migraineurs: a blinded controlled polysomnographic study. J Headache Pain 14:12
Ennis ZN, Dideriksen D, Vægter HB, Handberg G, Pottegård A (2016) Acetaminophen for chronic pain: a systematic review on efficacy. Basic Clin Pharmacol Toxicol 118:184–189
Esposito E, Paterniti I, Mazzon E, Bramanti P, Cuzzocrea S (2010) Melatonin reduces hyperalgesia associated with inflammation. J Pineal Res 49:321–331
Fingland R, Cronin A, Keifer J, Shaheen J, Davies M, Bixler E (1999) Postoperative REM sleep inhibition: association with pain or cortisol? Reg Anesth Pain Med 24:4
Galley HF, Mccormick B, Wilson KL, Lowes DA, Colvin L, Torsney C (2017) Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat. J Pineal Res 63:e12444
Gogenur I (2010) Postoperative circadian disturbances. Dan Med Bull 57:B4205
Gögenur I, Wildschiøtz G, Rosenberg J (2007) Circadian distribution of sleep phases after major abdominal surgery. Br J Anaesth 100:45–49
Gonçalves AL, Ferreira AM, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MFP (2016) Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry 87:1127–1132
Govitrapong P, Pariyanonth M, Ebadi M (1992) The presence and actions of opioid receptors in bovine pineal gland. J Pineal Res 13:124–132
Grigg-Damberger MM, Ianakieva D (2017) Poor quality control of over-the-counter melatonin: what they say is often not what you get. J Clin Sleep Med 13:163
Guglielmo R, Martinotti G, Di Giannantonio M, Janiri L (2013) A possible new option for migraine management: agomelatine. Clin Neuropharmacol 36:65–67
Hansson P (2004) Post-stroke pain case study: clinical characteristics, therapeutic options and long-term follow-up. Eur J Neurol 11:22–30
Hardeland R (1996) Ubiquitous melatonin-presence and effects in unicells, plants and animals. Trends Comp Biochem Physiol 2:25–45
Hardeland R (1999) Melatonin and 5-methoxytryptamine in non-metazoans. Reprod Nutr Dev 39:399–408
Hardeland R, Poeggeler B (2003) Non-vertebrate melatonin. J Pineal Res 34:233–241
Hernández-Pacheco A, Araiza-Saldaña CI, Granados-Soto V, Mixcoatl-Zecuatl T (2008) Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin. Eur J Pharmacol 596:70–76
Hussain SAR, Al-Khalifa II, Jasim NA, Gorial FI (2011) Adjuvant use of melatonin for treatment of fibromyalgia. J Pineal Res 50:267–271
Ismail SA, Mowafi HA (2009) Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia. Anesth Analg 108:1146–1151
Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343:769–772
Kalsbeek A, Palm I, La Fleur S, Scheer F, Perreau-Lenz S, Ruiter M, Kreier F, Cailotto C, Buijs R (2006) SCN outputs and the hypothalamic balance of life. J Biol Rhythm 21:458–469
Kärkelä J, Vakkuri O, Kaukinen S, Huang WQ, Pasanen M (2002) The influence of anaesthesia and surgery on the circadian rhythm of melatonin. Acta Anaesthesiol Scand 46:30–36
Kavaliers M (1989) β-Funaltrexamine disrupts the day-night rhythm of nociception in mice. Brain Res Bull 22:783–785
Kawabata A, Manabe S, Manabe Y, Takagi H (1994) Effect of topical administration of l-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 112:547–550
Kelman L, Rains JC (2005) Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 45:904–910
Khaldy H, León J, Escames G, Bikjdaouene L, García JJ, Acuña-Castroviejo D (2002) Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology 75:201–208
Kilic Ü, Kilic E, Reiter RJ, Bassetti CL, Hermann DM (2005) Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res 38:67–71
Klerman EB, Goldenberg DL, Brown EN, Maliszewski AM, Adler GK (2001) Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab 86:1034–1039
Klit H, Finnerup NB, Jensen TS (2009) Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol 8:857–868
Klit H, Hansen AP, Marcussen NS, Finnerup NB, Jensen TS (2014) Early evoked pain or dysesthesia is a predictor of central poststroke pain. Pain 155:2699–2706
Laurido C, Pelissier T, Soto-Moyano R, Valladares L, Flores F, Hernández A (2002) Effect of melatonin on rat spinal cord nociceptive transmission. Neuroreport 13:89–91
Leon J, Acuña-Castroviejo D, Escames G, Tan DX, Reiter RJ (2005) Melatonin mitigates mitochondrial malfunction. J Pineal Res 38:1–9
Li S-R, Wang T, Wang R, Dai X, Chen Q (2005) Melatonin enhances antinociceptive effects of δ-, but not μ-opioid agonist in mice. Brain Res 1043:132–138
Lieberman HR, Waldhauser F, Garfield G, Lynch HJ, Wurtman RJ (1984) Effects of melatonin on human mood and performance. Brain Res 323:201–207
Lissoni P, Giani L, Zerbini S, Trabattoni P, Rovelli F (1998) Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms. Nat Immun 16:27–33
Liu Y, He H, Huang F (2014) Melatonin in pain modulation: analgesic or proalgesic? Pain Stud Treatment 2:50
Liveing E (1873) On megrim, sick-headache, and some allied disorders: a contribution to the pathology of nerve-storms. Churchill, London
López-Canul M, Comai S, Domínguez-López S, Granados-Soto V, Gobbi G (2015) Antinociceptive properties of selective MT2 melatonin receptor partial agonists. Eur J Pharmacol 764:424–432
Lu W, Gwee K, Moochhalla S, Ho K (2005) Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 22:927–934
Luchetti F, Betti M, Canonico B, Arcangeletti M, Ferri P, Galli F, Papa S (2009) ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells. Free Radic Biol Med 46:339–351
Luchetti F, Canonico B, Curci R, Battistelli M, Mannello F, Papa S, Tarzia G, Falcieri E (2006) Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. J Pineal Res 40:158–167
Mahdi AA, Fatima G, Das SK, Verma NS (2011) Abnormality of circadian rhythm of serum melatonin and other biochemical parameters in fibromyalgia syndrome. Indian J Biochem Biophys 48:82–87
Maitra S, Baidya DK, Khanna P (2013) Melatonin in perioperative medicine: current perspective. Saudi J Anaesth 7:315
Makay B (2009) Is there a role of melatonin in the development of growing pains? Med Hypotheses 72:225
Martin M, Macias M, Escames G, Reiter R, Agapito M, Ortiz G, Acuña-Castroviejo D (2000) Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 28:242–248
Matsumoto M (1999) The hypnotic effects of melatonin treatment on diurnal sleep in humans. Psychiatry Clin Neurosci 53:243–245
Mayo JC, Sainz RM, Tan D-X, Hardeland R, Leon J, Rodriguez C, Reiter RJ (2005) Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 165:139–149
Mcintyre IM, Norman TR, Burrows GD, Armstrong SM (1993) Alterations to plasma melatonin and cortisol after evening alprazolam administration in humans. Chronobiol Int 10:205–213
Mondaca M, Hernández A, Valladares L, Sierralta W, Noseda R, Soto-Moyano R (2004) Involvement of melatonin metabolites in the long-term inhibitory effect of the hormone on rat spinal nociceptive transmission. Pharmacol Biochem Behav 77:275–279
Moore RY, Speh JC (1993) GABA is the principal neurotransmitter of the circadian system. Neurosci Lett 150:112–116
Morgan PJ, Williams LM (1996) The pars tuberalis of the pituitary: a gateway for neuroendocrine output. Rev Reprod 1:153–161
Mowafi HA, Ismail SA (2008) Melatonin improves tourniquet tolerance and enhances postoperative analgesia in patients receiving intravenous regional anesthesia. Anesth Analg 107:1422–1426
Muñóz-Hoyos A, Fernández-García J, Molina-Carballo A, Macias M, Escames G, Ruiz-Cosano C, Acuña-Castroviejo D (2000) Effect of clonidine on plasma ACTH, cortisol and melatonin in children. J Pineal Res 29:48–53
Murphy PJ, Myers BL, Badia P (1996) Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 59:133–139
Naguib M, Gottumukkala V, Goldstein PA (2007) Melatonin and anesthesia: a clinical perspective. J Pineal Res 42:12–21
Nahleh Z, Pruemer J, Lafollette J, Sweany S (2010) Melatonin, a promising role in taxane-related neuropathy. Clin Med Insights Oncol 4., CMO:S4132
Naseem M, Parvez S (2014) Role of melatonin in traumatic brain injury and spinal cord injury. Sci World J 2014:586270
Noseda R, Hernández A, Valladares L, Mondaca M, Laurido C, Soto-Moyano R (2004) Melatonin-induced inhibition of spinal cord synaptic potentiation in rats is MT 2 receptor-dependent. Neurosci Lett 360:41–44
Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G (2009) Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 47:82–96
Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP (2008) Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 85:335–353
Park HJ (2014) Chemotherapy induced peripheral neuropathic pain. Korean J Anesthesiol 67:4–7
Pasternak GW (2007) When it comes to opiates, just say NO. J Clin Invest 117:3185–3187
Patel T, Kurdi MS (2015) A comparative study between oral melatonin and oral midazolam on preoperative anxiety, cognitive, and psychomotor functions. J Anaesthesiol Clin Pharmacol 31:37
Paul KN, Losee-Olson S, Pinckney L, Turek FW (2009) The ability of stress to alter sleep in mice is sensitive to reproductive hormones. Brain Res 1305:74–85
Peres M, Gonçalves A (2013) Double-blind, placebo controlled, randomized clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. Neurology 80:S40.005
Perissin L, Boccalon S, Scaggiante B, Petrelli L, Ortolani F, Porro CA (2004) Diurnal changes of tonic nociceptive responses in mice: evidence for a proalgesic role of melatonin. Pain 110:250–258
Phansuwan-Pujito P, Ebadi M, Govitrapong P (2006) Immunocytochemical characterization of delta-opioid and mu-opioid receptor protein in the bovine pineal gland. Cells Tissues Organs 182:48–56
Pickard GE (1987) Circadian rhythm of nociception in the golden hamster. Brain Res 425:395–400
Poeggeler B, Balzer I, Hardeland R, Lerchl A (1991) Pineal hormone melatonin oscillates also in the dinoflagellate Gonyaulax polyedra. Naturwissenschaften 78:268–269
Ray M, Mediratta P, Mahajan P, Sharma K (2004) Evaluation of the role of melatonin in formalin-induced pain response in mice. Indian J Med Sci 58:122
Reiter RJ, Tan DX, Sainz RM, Mayo JC, Lopez-BURILLO S (2002) Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 54:1299–1321
Rosenstein RE, Cardinali DP (1986) Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Res 398:403–406
Rudra DS, Pal U, Maiti NC, Reiter RJ, Swarnakar S (2013) Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site. J Pineal Res 54:398–405
Sahota P (2003) Morning headaches in patients with sleep disorders. Sleep Med 4(5):377.
Schernhammer E, Schulmeister K (2004) Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer 90:941
Shavali S, Ho B, Govitrapong P, Sawlom S, Ajjimaporn A, Klongpanichapak S, Ebadi M (2005) Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of β-endorphin an endogenous opioid. Brain Res Bull 64:471–479
Shin DJ, Jeong CW, Lee SH, Yoon MH (2011) Receptors involved in the antinociception of intrathecal melatonin in formalin test of rats. Neurosci Lett 494:207–210
Siah KTH, Wong RKM, Ho KY (2014) Melatonin for the treatment of irritable bowel syndrome. World J Gastroenterol 20:2492
Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY (2005) Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 54:1402–1407
Srinivasan V, Lauterbach EC, HO KY, Acuña-Castroviejo D, Zakaria R, Brzezinski A (2012) Melatonin in antinociception: its therapeutic applications. Curr Neuropharmacol 10:167–178
Srinivasan V, Pandi-Perumal SR, Spence DW, Moscovitch A, Trakht I, Brown GM, Cardinali DP (2010) Potential use of melatonergic drugs in analgesia: mechanisms of action. Brain Res Bull 81:362–371
Srinivasan V, Spence DW, Pandi-Perumal SR, Brown GM, Cardinali DP (2011) Melatonin in mitochondrial dysfunction and related disorders. Int J Alzheimers Dis 2011:326320
Srinivasan V, Zakaria R, Singh HJ, Acuna-Castroviejo D (2013) Melatonin and its agonists in pain modulation and its clinical application. Arch Ital Biol 150:274–292
Starobova H, Vetter I (2017) Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci 10:174
Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W (1999) Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 55:111–115
Sultan SS (2010) Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly. Saudi J Anaesth 4:169
Tabeeva G, Sergeev A, Gromova S (2011) Possibilities of preventive treatment of migraine with the MT1-and MT2 agonist and 5-HT2с receptor antagonist agomelatin (valdoxan). Zh Nevrol Psikhiatr Im S S Korsakova 111:32–36
Ulugol A, Dokmeci D, Guray G, Sapolyo N, Ozyigit F, Tamer M (2006) Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: possible involvements of the L-arginine–NO pathway and opioid system. Life Sci 78:1592–1597
Van Den Heuvel CJ, Ferguson SA, Macchi MM, Dawson D (2005) Melatonin as a hypnotic: con. Sleep Med Rev 9:71–80
Vijayalaxmi, Thomas CRJR, Reiter RJ, Herman TS (2002) Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 20:2575–2601
Wang S, Tian Y, Song L, Lim G, Tan Y, You Z, Chen L, Mao J (2012) Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors. Pain 153:2448–2457
Weaver DR, Dallmann R (n.d.) Melatonin receptors: past, present and future
Weaver DR, Rivkees SA, Reppert SM (1989) Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography. J Neurosci 9:2581–2590
Wiech K, Tracey I (2009) The influence of negative emotions on pain: behavioral effects and neural mechanisms. NeuroImage 47:987–994
Wikner J, Hirsch U, Wetterberg L, Röjdmark S (1998) Fibromyalgia—a syndrome associated with decreased nocturnal melatonin secretion. Clin Endocrinol 49:179–183
Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gögenur I (2011) Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res 51:270–277
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28
Xiong X-C, Zhu Y, Ge R, Liu L-F, Yuan W (2015) Effect of melatonin on the extracellular-regulated kinase signal pathway activation and human osteoblastic cell line hFOB 1.19 proliferation. Int J Mol Sci 16:10337–10353
Xu R, Wu X, Di A, Xu J, Pang C, Pang S, Meng Z, Lu G-W, Wang Q, Wu Y (2000) Receptor and non-receptor mediated actions of melatonin. Neurosignals 9:53–75
Yousaf F, Seet E, Venkatraghavan L, Abrishami A, Chung F (2010) Efficacy and safety of melatonin as an anxiolytic and analgesic in the perioperative Period: A qualitative systematic review of randomized trials. Anesthesiology 113:968–976
Yu C, Wu G, Xu S, Chen C (2000) Melatonin influences the release of endogenous opioid peptides in rat periaqueductal gray. Sheng Li Xue Bao 52:207–210
Zahn PK, Lansmann T, Berger E, Speckmann EJ, Musshoff U (2003) Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat: implications for pain modulation. J Pineal Res 35:24–31
Zhu C, Xu Y, Duan Y, LI W, Zhang L, Huang Y, Zhao W, Wang Y, Li J, Feng T (2017) Exogenous melatonin in the treatment of pain: a systematic review and meta-analysis. Oncotarget 8:100582
Zurowski D, Nowak L, Machowska A, Wordliczek J, Thor P (2012) Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism. J Physiol Pharmacol 63:641–647
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kaur, T., Shyu, BC. (2018). Melatonin: A New-Generation Therapy for Reducing Chronic Pain and Improving Sleep Disorder-Related Pain. In: Shyu, BC., Tominaga, M. (eds) Advances in Pain Research: Mechanisms and Modulation of Chronic Pain. Advances in Experimental Medicine and Biology, vol 1099. Springer, Singapore. https://doi.org/10.1007/978-981-13-1756-9_19
Download citation
DOI: https://doi.org/10.1007/978-981-13-1756-9_19
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1755-2
Online ISBN: 978-981-13-1756-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)